Cns Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-11-19
Clinical Trial Update: A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating repotrectinib in pediatric and young adult patients with ALK, ROS1, or NTRK1-3 alterations in locally …